Results of a phase 2 trial of the monocyte-targeted histone deacetylase inhibitor tefinostat (CHR-2845) in chronic myelomonocytic leukemia (CMML) - the UK Monocle study
Knapper, S Dennis, Michael Drummond, W Hills, K Dillon, J Pocock, C Culligan, J Vyas, P Wiseman, D Zabkiewicz, J
Knapper, S
Dennis, Michael
Drummond, W
Hills, K
Dillon, J
Pocock, C
Culligan, J
Vyas, P
Wiseman, D
Zabkiewicz, J
Citations
Altmetric:
Abstract
Description
Date
2018
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Knapper S, Dennis M, Drummond M, Hills R, Dillon R, Pocock C, et al.Results of a phase 2 trial of the monocyte-targeted histone deacetylase inhibitor tefinostat (CHR-2845) in chronic myelomonocytic leukemia (CMML) - the UK Monocle study. Blood. 2018;132.